These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35853766)

  • 1. Unexpected Late Response to Ofatumumab in Adult Post-Transplantation Recurrent Focal Segmental Glomerulosclerosis, Case Report.
    Ural Z; Helvacı Ö; Özbaş B; Güz G; Derici Ü
    Transplant Proc; 2022; 54(6):1632-1635. PubMed ID: 35853766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent Focal Segmental Glomerulosclerosis and Abatacept: Case Report.
    Alkandari O; Nampoory N; Nair P; Atta A; Zakaria Z; Mossad A; Yagan J; Al-Otaibi T
    Exp Clin Transplant; 2016 Aug; 14(4):456-9. PubMed ID: 25432003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Treatment of Recurrent Focal Segmental Glomerulosclerosis After Transplantation in Children: A Single-Center Experience.
    Alhasan KA; Alherbish A; Osman A; Kari JA; Almojalli H
    Transplant Proc; 2019 Mar; 51(2):517-521. PubMed ID: 30879580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ofatumumab rescue treatment in post-transplant recurrence of focal segmental glomerulosclerosis.
    Colucci M; Labbadia R; Vivarelli M; Camassei FD; Emma F; Dello Strologo L
    Pediatr Nephrol; 2020 Feb; 35(2):341-345. PubMed ID: 31667616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ofatumumab in post-transplantation recurrence of focal segmental glomerulosclerosis in a child.
    Solomon S; Zolotnitskaya A; Del Rio M
    Pediatr Transplant; 2019 Jun; 23(4):e13413. PubMed ID: 30973669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.
    Tsagalis G; Psimenou E; Nakopoulou L; Laggouranis A
    Artif Organs; 2011 Apr; 35(4):420-5. PubMed ID: 20637013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of ofatumumab and eplerenone in post-transplant recurrence of FSGS.
    Jain NG; Chen JK; Mahajan R; Kehoe J; Singer P; Whyte D; Bomback AS
    Pediatr Transplant; 2022 Mar; 26(2):e14191. PubMed ID: 34806263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue with obinutuzumab and daratumumab as combined B cell/plasma cell targeting approach in severe posttransplant focal segmental glomerulosclerosis recurrence.
    Randone P; Sanna E; Dolla C; Gallo E; Mingozzi S; Tarragoni R; Torazza MC; Niarchos A; Mella A; Manzione AM; Barreca A; Deambrosis I; Giraudi R; Biancone L
    Am J Transplant; 2024 Oct; 24(10):1896-1900. PubMed ID: 39029875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of FSGS after Kidney Transplantation in Adults.
    Uffing A; Pérez-Sáez MJ; Mazzali M; Manfro RC; Bauer AC; de Sottomaior Drumond F; O'Shaughnessy MM; Cheng XS; Chin KK; Ventura CG; Agena F; David-Neto E; Mansur JB; Kirsztajn GM; Tedesco-Silva H; Neto GMV; Arias-Cabrales C; Buxeda A; Bugnazet M; Jouve T; Malvezzi P; Akalin E; Alani O; Agrawal N; La Manna G; Comai G; Bini C; Muhsin SA; Riella MC; Hokazono SR; Farouk SS; Haverly M; Mothi SS; Berger SP; Cravedi P; Riella LV
    Clin J Am Soc Nephrol; 2020 Feb; 15(2):247-256. PubMed ID: 31974287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of recurrent focal segmental glomerulosclerosis after kidney transplantation associated with variant conversion in the Columbia classification.
    Unagami K; Kawanishi K; Shimizu T; Kanzawa T; Toki D; Okumi M; Omoto K; Horita S; Koike J; Honda K; Nagashima Y; Ishida H; Tanabe K; Nitta K
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():96-100. PubMed ID: 26031598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal segmental glomerulosclerosis in pediatric kidney transplantation: 30 years' experience.
    Cleper R; Krause I; Bar Nathan N; Mor M; Dagan A; Weissman I; Frishberg Y; Rachamimov R; Mor E; Davidovits M
    Clin Transplant; 2016 Oct; 30(10):1324-1331. PubMed ID: 27490751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different effects of rituximab on a native kidney and a post-transplant kidney with recurrence of focal segmental glomerulosclerosis.
    Ino A; Kaori S; Takei T; Nitta K
    CEN Case Rep; 2020 Aug; 9(3):195-199. PubMed ID: 31997159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-operative recurrence of focal segmental glomerulosclerosis according to pre-transplant treatment after kidney transplantation.
    Kwon HE; Kim YH; Lee SA; Lee JJ; Ko Y; Shin S; Jung JH; Sung FS; Baek CH; Kim H; Park SK; Kwon H
    BMC Nephrol; 2023 Mar; 24(1):53. PubMed ID: 36922759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pretransplant plasmapheresis and rituximab on recurrence of focal segmental glomerulosclerosis in adult renal transplant recipients.
    Park HS; Hong Y; Sun IO; Chung BH; Kim HW; Choi BS; Park CW; Jin DC; Kim YS; Yang CW
    Korean J Intern Med; 2014 Jul; 29(4):482-8. PubMed ID: 25045296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UK experience of ofatumumab in recurrence of focal segmental glomerulosclerosis post-kidney transplant.
    Reynolds BC; Lamb A; Jones CA; Yadav P; Tyerman KS; Geddes CC
    Pediatr Nephrol; 2022 Jan; 37(1):199-207. PubMed ID: 34383125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined rituximab and plasmapheresis or plasma exchange for focal segmental glomerulosclerosis in adult kidney transplant recipients: a meta-analysis.
    Hansrivijit P; Ghahramani N
    Int Urol Nephrol; 2020 Jul; 52(7):1377-1387. PubMed ID: 32306197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Treatment With Abatacept in Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplant.
    Shah Y; Almeshari K; Aleid H; Broering D; Alahmadi I; Ali T
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):178-180. PubMed ID: 30777550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
    Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T
    Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete Remission of Post-transplantation Recurrence of Focal Segmental Glomerulosclerosis With the Use of Adrenocorticotrophic Hormone Gel: Case Report.
    Mittal T; Dedhia P; Roy-Chaudhury P; Abu Jawdeh BG; Mogilishetty G; Cuffy MC; Alloway RR; Woodle ES; Govil A
    Transplant Proc; 2015 Sep; 47(7):2219-22. PubMed ID: 26361683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis and immunoadsorption for treatment and prophylaxis of recurrent focal segmental glomerulosclerosis in adult recipients of deceased donor renal grafts.
    Kandus A; Ponikvar R; Buturović-Ponikvar J; Bren AF; Oblak M; Mlinšek G; Kmetec A; Arnol M
    Ther Apher Dial; 2013 Aug; 17(4):438-43. PubMed ID: 23931886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.